Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.

Frontiers in immunology - 1 Jan 2020

Shamriz Oded, Tal Yuval, Talmon Aviv, Nahum Amit

Abstract excerpt

Children with chronic mucocutaneous candidiasis (CMC) experience recurrent infections with Candida spp. Moreover, immune dysregulation in the early life of these patients induces various autoimmune diseases and affects normal growth and development. The adaptive and innate immune system components play a significant role in anti-fungal response. This response is mediated through IL-17 production by T helper...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Autoantibodies
Share to Autoimmunity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Candida

Share to Candidiasis, Chronic Mucocutaneous

Share to Disease Management

Share to Host-Pathogen Interactions

Share to Molecular Targeted Therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 33178226
DOI: 10.3389/fimmu.2020.593289
PMCID: PMC7596184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.PMID 33178226Read ↗

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunitySemantic proximity Read ↗

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.Semantic proximity Read ↗

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasisSemantic proximity Read ↗

Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.Semantic proximity Read ↗

Human inborn errors of immunity underlying superficial or invasive candidiasis.Semantic proximity Read ↗

Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.Semantic proximity Read ↗

TH17 deficiency in human disease.Semantic proximity Read ↗

Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.Semantic proximity Read ↗

New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.Semantic proximity Read ↗

A Novel IL17RA Mutation In A Male Child With Chronic Mucocutaneous CandidiasisSemantic proximity Read ↗

A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.Semantic proximity Read ↗

Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.